IlluminOss Medical, a manufacturer of photodynamic orthopedic implants, has secured a $28 million Series C round of venture capital financing. The minimally invasive IlluminOss Photodynamic Bone Stabilization System is used to treat fractures through a small entry into the bone. A flexible balloon catheter is inserted into the bone, placed across the fracture site, and infused with a proprietary liquid monomer. The monomer then expands the balloon to assist in the alignment of the fractured bone, and surgeons use a visible light source to illuminate it and convert it into a hardened polymer implant.
More Articles on Orthopedic Devices:
Amedica Receives FDA Approval for Interbody Fusion Device
Smith & Nephew Devices Approved For Additional Indications
Alphatec Spine to Acquire Some Assets of Phygen